CARA - JD BILI and CARA among pre market gainers
Triple-S Management (NYSE:GTS) +44% to be acquired by GuideWell in an all-cash deal worth $900 million Bio-Path (NASDAQ:BPTH) +32% on FDA clearance of BP1002 application in acute myeloid leukemia Cara Therapeutics (NASDAQ:CARA) +21% and Vifor Pharma announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients Eastside Distilling (NASDAQ:EAST) +15%. Pinduoduo (NASDAQ:PDD) +12% on Q2 earnings. 36Kr Holdings (NASDAQ:KRKR) +12% on Q2 earnings. Palo Alto Networks (NYSE:PANW) +11% on FQ4 earnings. 4D pharma (NASDAQ:LBPS) +9%. JD.com (NASDAQ:JD) +9%. Bilibili (NASDAQ:BILI) +7%. Orphazyme A/S (NASDAQ:ORPH) +6% published results from its phase 2/3 trial of Arimoclomol in niemann-pick disease type C SuperCom (NASDAQ:SPCB) +6% wins and launches new project in California Heritage Global (NASDAQ:HGBL) +6% acquiring American Laboratory Trading Camping World (NYSE:CWH) +6% doubles quarterly dividend; yield rises to 5.4% China Liberal Education (NASDAQ:CLEU) +6%. Tencent Music Entertainment (NYSE:TME) +6%. Arcimoto (NASDAQ:FUV) +6%. Huize (NASDAQ:HUIZ) +6%. UP Fintech (NASDAQ:TIGR) +6%. Futu (NASDAQ:FUTU) +6%. OpGen. (NASDAQ:OPGN) +6%. Aehr Test Systems (NASDAQ:AEHR) +5% on $3M
For further details see:
JD, BILI and CARA among pre market gainers